COVID-19患者俯卧位对体外膜氧合的影响
该研究为多中心回顾性队列分析,纳入41个中心647例接受静脉-静脉ECMO的COVID-19相关ARDS患者中的517例。插管前95%患者已行俯卧位;插管后364例(70%)继续俯卧位,153例(30%)全程仰卧位。俯卧位组住院死亡194例(53%),仰卧位组92例(60%);ECMO期间俯卧位与住院死亡率降低独立相关(OR=0.49 [0.29-0.84];p=0.010)。153对倾向性评分匹配后,俯卧位组死亡率49.7% vs 仰卧位组60.1%(p=0.085);仅分析拔管时存活患者,匹配后俯卧位组死亡率22.4% vs 37.8%(p=0.029)。作者认为COVID-19相关ARDS接受静脉-静脉ECMO期间俯卧位可能获益,但需更多数据才能得出确定性结论。
要点
- 插管后继续俯卧位者占70%(364/517),全程仰卧位者占30%(153/517);俯卧位组住院死亡53%(194例),仰卧位组60%(92例)。
- ECMO期间俯卧位与住院死亡率降低独立相关:OR=0.49(95%CI 0.29-0.84),p=0.010。
- 153对倾向性评分匹配后,俯卧位组死亡率49.7% vs 仰卧位组60.1%,p=0.085,未达统计学显著。
- 仅分析拔管时存活患者,匹配后俯卧位组死亡率22.4% vs 仰卧位组37.8%,p=0.029。
- 作者认为俯卧位可能对COVID-19相关ARDS的静脉-静脉ECMO患者有益,但需更多数据才能得出确定性结论。
适用人群与场景
- 接受静脉-静脉ECMO的COVID-19相关ARDS患者,严重急性呼吸综合征冠状病毒2逆转录聚合酶链反应阳性或胸部CT诊断。
- 纳入标准:接受静脉-静脉ECMO治疗呼吸衰竭,且ECMO期间俯卧位状态和住院死亡率已知的患者。
- 共41个中心647例中517例纳入;中位年龄55岁(47-61),男性78%,插管前95%曾行俯卧位。
研究设计与关键结果
- 研究设计:多中心队列回顾性分析,41个中心647例中纳入517例接受静脉-静脉ECMO的COVID-19相关ARDS患者。
- 插管后364例(70%)行俯卧位,153例(30%)全程仰卧位;俯卧位组住院死亡194例(53%),仰卧位组92例(60%)。
- ECMO期间俯卧位与住院死亡率降低独立相关:OR=0.49(95%CI 0.29-0.84),p=0.010。
- 153对倾向性评分匹配后,俯卧位组死亡率49.7% vs 仰卧位组60.1%,p=0.085。
- 仅分析拔管时存活患者,匹配后俯卧位组死亡率22.4% vs 仰卧位组37.8%,p=0.029。
证据类型、等级与局限
- 证据类型:多中心回顾性队列分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对COVID-19相关ARDS接受静脉-静脉ECMO的患者,俯卧位可能有益,但需更多数据才能得出确定性结论。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Prone positioning and venovenous extracorporeal membrane oxygenation (ECMO) are both useful interventions in acute respiratory distress syndrome (ARDS). Combining the two therapies is feasible and safe, but the effectiveness is not known. Our objective was to evaluate the potential survival benefit of prone positioning in venovenous ECMO patients cannulated for COVID-19-related ARDS.
DESIGN: Retrospective analysis of a multicenter cohort.
PATIENTS: Patients on venovenous ECMO who tested positive for severe acute respiratory syndrome coronavirus 2 by reverse transcriptase polymerase chain reaction or with a diagnosis on chest CT were eligible.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: All patients on venovenous ECMO for respiratory failure in whom prone position status while on ECMO and in-hospital mortality were known were included. Of 647 patients in 41 centers, 517 were included. Median age was 55 (47-61), 78% were male and 95% were proned before cannulation. After cannulation, 364 patients (70%) were proned and 153 (30%) remained in the supine position for the whole ECMO run. There were 194 (53%) and 92 (60%) deaths in the prone and the supine groups, respectively. Prone position on ECMO was independently associated with lower in-hospital mortality (odds ratio = 0.49 [0.29-0.84]; p = 0.010). In 153 propensity score-matched pairs, mortality rate was 49.7% in the prone position group versus 60.1% in the supine position group (p = 0.085). Considering only patients alive at decannulation, propensity-matched proned patients had a significantly lower mortality rate (22.4% vs 37.8%; p = 0.029) than nonproned patients.
CONCLUSIONS: Prone position may be beneficial in patients supported by venovenous ECMO for COVID-19-related ARDS but more data are needed to draw definitive conclusions.
参考来源
- Massart N, Guervilly C, Mansour A, et al. Impact of Prone Position in COVID-19 Patients on Extracorporeal Membrane Oxygenation. Crit Care Med. 2022. PMID: 36519982. doi:10.1097/CCM.0000000000005714
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。